SOD1 and metabolic syndrome: Partially different results were presented by Vichaibun et al. According to this publication, TAC significantly decreases, and SOD activity significantly increases in people with hyperglycemia as well as hyperglycemia and dyslipidemia compared to the control group, without a significant difference between people with hyperglycemia and hyperglycemia coexisting with dyslipidemia [63].